Shares of BioArctic AB tumbled by 7% on Friday following news that the European Commission (EC) has requested further review of the company's Alzheimer's drug, lecanemab, by the Committee for Medicinal Products for Human Use (CHMP).

The European Commission has published on the 29th January the “Competitiveness Compass for the EU”, setting out ambitious initiatives aimed

The European Commission said on Friday that it has launched infringement procedures against Bulgaria for failing to fully transpose seven EU directives related

Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Dato-DXd marketed with AstraZeneca (NASDAQ:AZN) as a late-line option for certain cases of breast cancer.

Akhtar Ahmed, senior secretary of the Election Commission (EC), said that the European Union (EU) has emphasized the need to restore voter confidence. On Thursday, ahead of a meeting with the Election Commission at Agargaon,

Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended

AMM Nasir Uddin on Tuesday said the European Union (EU) has put emphasis on reform and assured all sorts of assistance ahead of the next general election. “They (EU) are ready to provide all sorts of assistance.

The European Commission (EC) has presented data regarding several criminal proceedings linked to the enforcement of EU law, with Bulgaria involved in seven of these cases. In the realm of crime prevention,

Unife has warned that EU member states are at risk of losing funding for vital rail schemes promised in the EU's Recovery and Resilience Facility.

Projects will contribute to the European Union’s 2030 target of 50 million tpa of CO2 injection capacity as bloc pushes to decarbonise its energy system

The European Union's upcoming Digital Fairness Act has the potential to end exploitative practices online and enhance consumer protection throughout the modern digital ecosystem, but civil society gro

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as